A patient on antidiabetic therapy reports passing blood in urine for the past three days; which drug could cause this adverse effect?

Study for the Foundation Year Pharmacy – Clinical Practice Test. Prepare with detailed questions, step-by-step explanations, and test format insights. Enhance your readiness and confidence!

Multiple Choice

A patient on antidiabetic therapy reports passing blood in urine for the past three days; which drug could cause this adverse effect?

Hematuria signals a possible bladder or urinary tract issue. Among common antidiabetic agents, pioglitazone has been linked to an increased risk of bladder cancer with long-term use, and bladder pathology can present with blood in the urine. The other medications listed have different adverse effect profiles (metformin mainly GI upset and rare lactic acidosis; acarbose causes GI gas; exenatide can cause pancreatitis and GI symptoms) and are not associated with hematuria as a notable adverse effect. Therefore, pioglitazone is the drug most plausibly connected to this symptom. If this occurs, it warrants clinical evaluation for bladder pathology regardless of diabetes therapy.

Hematuria signals a possible bladder or urinary tract issue. Among common antidiabetic agents, pioglitazone has been linked to an increased risk of bladder cancer with long-term use, and bladder pathology can present with blood in the urine. The other medications listed have different adverse effect profiles (metformin mainly GI upset and rare lactic acidosis; acarbose causes GI gas; exenatide can cause pancreatitis and GI symptoms) and are not associated with hematuria as a notable adverse effect. Therefore, pioglitazone is the drug most plausibly connected to this symptom. If this occurs, it warrants clinical evaluation for bladder pathology regardless of diabetes therapy.

More practice questions